Pharmaceutical

Innate shelves lacutamab monotherapy plans in peripheral T cell lymphoma

A combo trial will continue as planned in addition to the biotech’s cutaneous T Cell lymphoma programme.

Mar 24, 2024 - 00:00
Innate shelves lacutamab monotherapy plans in peripheral T cell lymphoma
A combo trial will continue as planned in addition to the biotech’s cutaneous T Cell lymphoma programme.
Read the original article

Tags:

Previous Article

Pharmaceutical consulting companies, pharmaceutical training and other developme...

Next Article

Chinook Therapeutics files patent for improving kidney function in a subject

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Medicare threatens to pull funding from HCA’s embattled Mission Hospital

STAT+: Medicare threatens to pull funding from HCA’s em...

Feb 7, 2024

STAT+: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls

STAT+: FDA inspection underscores problem at major U.S....

Jul 26, 2023

FDA approves Luye Pharma’s ERZOFRI for schizophrenia

FDA approves Luye Pharma’s ERZOFRI for schizophrenia

Jul 30, 2024